Objective To elucidate the diagnosis and surgical treatment of the posterior fossa solid hemangio^blastomas (PFSHs) Methods The data from 22 patients with PFSHs verified by surgery and pathology were analyzed retro...Objective To elucidate the diagnosis and surgical treatment of the posterior fossa solid hemangio^blastomas (PFSHs) Methods The data from 22 patients with PFSHs verified by surgery and pathology were analyzed retrospectively and a review of relevant literature was conducted Results The preoperative definitive diagnosis rate was 13/22 Total tumor removal was achieved in 20 patients Two of the 22 patients died after surgery, one of brain stem injury and the other from an intracranial hemorrhage Twenty patients were followed up for 2 months to 8 yeas (average, 2 years) Karnofsky scale was 80 in 15 patients, 60-70 in 1 patient and not measured in 4 patients who died during follow up The causes of death were pneumonia (2 patients) and purulent meningitis (2) Conclusion MRI and DSA (digital subtraction angiography) are major preoperative diagnostic modalities for PFSH, but PFSH remains a challenging benign neoplasm Special microsurgical techniques and improved operative manipulation can improve surgical efficacy展开更多
目的评估术前栓塞辅助开放手术治疗实性血管母细胞瘤的安全性及有效性。方法通过检索万方数据库、中国期刊网全文数据库、维普数据库、PubMed、Medline、Springer等中外数据库,获取关于术前栓塞联合开放手术治疗与单纯开放手术治疗实性...目的评估术前栓塞辅助开放手术治疗实性血管母细胞瘤的安全性及有效性。方法通过检索万方数据库、中国期刊网全文数据库、维普数据库、PubMed、Medline、Springer等中外数据库,获取关于术前栓塞联合开放手术治疗与单纯开放手术治疗实性血管母细胞瘤的文献,由2名医师独立选择、提取并交叉核对数据,并对其方法学进行质量评价,使用RevMan5.3软件对筛选之后符合纳入及排除标准的文献进行Meta分析。结果共有8篇文献纳入Meta分析,结果显示,实性血管母细胞瘤术前辅助栓塞联合手术治疗与单纯手术治疗组手术时间、失血量、输血量和手术全切率比较,差异有统计学意义(P<0.00001,WMD(Weighted Mean Difference,加权均数差)=-1.18,95%CI为-1.16,-0.71;P<0.00001,WMD=-464.17,95%CI为[-492.17,-437.24];P<0.00001,WMD=-238.81,95%CI为-282.84,-194.77;P<0.006,RR(Risk Ratio,相对危险度)=1.17,95%CI为[1.05,1.31])。结论实性血管母细胞瘤行术前辅助栓塞有利于缩短手术时间,减少术中失血量与输血量,提高肿瘤的全切率。展开更多
文摘Objective To elucidate the diagnosis and surgical treatment of the posterior fossa solid hemangio^blastomas (PFSHs) Methods The data from 22 patients with PFSHs verified by surgery and pathology were analyzed retrospectively and a review of relevant literature was conducted Results The preoperative definitive diagnosis rate was 13/22 Total tumor removal was achieved in 20 patients Two of the 22 patients died after surgery, one of brain stem injury and the other from an intracranial hemorrhage Twenty patients were followed up for 2 months to 8 yeas (average, 2 years) Karnofsky scale was 80 in 15 patients, 60-70 in 1 patient and not measured in 4 patients who died during follow up The causes of death were pneumonia (2 patients) and purulent meningitis (2) Conclusion MRI and DSA (digital subtraction angiography) are major preoperative diagnostic modalities for PFSH, but PFSH remains a challenging benign neoplasm Special microsurgical techniques and improved operative manipulation can improve surgical efficacy
文摘目的评估术前栓塞辅助开放手术治疗实性血管母细胞瘤的安全性及有效性。方法通过检索万方数据库、中国期刊网全文数据库、维普数据库、PubMed、Medline、Springer等中外数据库,获取关于术前栓塞联合开放手术治疗与单纯开放手术治疗实性血管母细胞瘤的文献,由2名医师独立选择、提取并交叉核对数据,并对其方法学进行质量评价,使用RevMan5.3软件对筛选之后符合纳入及排除标准的文献进行Meta分析。结果共有8篇文献纳入Meta分析,结果显示,实性血管母细胞瘤术前辅助栓塞联合手术治疗与单纯手术治疗组手术时间、失血量、输血量和手术全切率比较,差异有统计学意义(P<0.00001,WMD(Weighted Mean Difference,加权均数差)=-1.18,95%CI为-1.16,-0.71;P<0.00001,WMD=-464.17,95%CI为[-492.17,-437.24];P<0.00001,WMD=-238.81,95%CI为-282.84,-194.77;P<0.006,RR(Risk Ratio,相对危险度)=1.17,95%CI为[1.05,1.31])。结论实性血管母细胞瘤行术前辅助栓塞有利于缩短手术时间,减少术中失血量与输血量,提高肿瘤的全切率。
